Brief: Guard Therapeutics Q3 Loss SEK 31.7 Mln
Nov 13 (Reuters) - Guard Therapeutics International AB
(publ) GUARD.ST :
* Q3 NET SALES: 0 KSEK (0)
* Q3 LOSS BEFORE AND AFTER TAX: KSEK 31,727
Source text: ID:nMFNch2byG
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover